BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22537361)

  • 1. Medicaid expenditures on psychotropic medications for children in the child welfare system.
    Raghavan R; Brown DS; Thompson H; Ettner SL; Clements LM; Key W
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):182-9. PubMed ID: 22537361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States.
    Raghavan R; Brown DS; Allaire BT; Garfield LD; Ross RE
    Psychiatr Serv; 2014 Dec; 65(12):1445-51. PubMed ID: 25178250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children.
    Raghavan R; Brown DS; Allaire BT; Garfield LD; Ross RE; Snowden LR
    Child Abuse Negl; 2014 Jun; 38(6):1002-10. PubMed ID: 24646610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Magnitude of Child Maltreatment and Medicaid Expenditures for Psychotropic Medications.
    Raghavan R; Brown DS; Allaire BT; Ross RE; Landsverk J
    Psychiatr Serv; 2016 Aug; 67(8):916-9. PubMed ID: 27032658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Expenditure Pharmaceutical Use Among Children in Medicaid.
    Cohen E; Hall M; Lopert R; Bruen B; Chamberlain LJ; Bardach N; Gedney J; Zima BT; Berry JG
    Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28765380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
    Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
    J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication use in a national probability sample of children in the child welfare system.
    Raghavan R; Zima BT; Andersen RM; Leibowitz AA; Schuster MA; Landsverk J
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):97-106. PubMed ID: 15741791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the use of psychotropic medications in the child welfare system: causes, consequences, and proposed solutions.
    Alavi Z; Calleja NG
    Child Welfare; 2012; 91(2):77-94. PubMed ID: 23362615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating geographic variation in use of psychotropic medications among youth in child welfare.
    Leslie LK; Raghavan R; Hurley M; Zhang J; Landsverk J; Aarons G
    Child Abuse Negl; 2011 May; 35(5):333-42. PubMed ID: 21620160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstate variations in psychotropic medication use among a national sample of children in the child welfare system.
    Raghavan R; Lama G; Kohl P; Hamilton B
    Child Maltreat; 2010 May; 15(2):121-31. PubMed ID: 20410022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid.
    Fox MH; Foster CH; Zito JM
    Am J Med Qual; 2000; 15(4):126-36. PubMed ID: 10948784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs associated with child maltreatment: impact on medicaid.
    Florence C; Brown DS; Fang X; Thompson HF
    Pediatrics; 2013 Aug; 132(2):312-8. PubMed ID: 23821692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication expenditures for community-dwelling elderly persons.
    Aparasu R; Mort J; Brandt H
    Psychiatr Serv; 2003 May; 54(5):739-42. PubMed ID: 12719508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort.
    Bondy J; Berman S; Glazner J; Lezotte D
    Pediatrics; 2000 Jun; 105(6):E72. PubMed ID: 10835085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of Medicaid mental health services by nondisabled children and adolescents.
    Buck JA
    Psychiatr Serv; 1997 Jan; 48(1):65-70. PubMed ID: 9117502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicaid expenditures for children living with smokers.
    Levy DE; Rigotti NA; Winickoff JP
    BMC Health Serv Res; 2011 May; 11():125. PubMed ID: 21612635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.